Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study.

Pulm Circ · 2023 · PMC10442608 · PMID 37614830

Europe PMC DOI

hedged sentences

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a nonsignificant trendp = 0.09so close (0.05 < p ≤ 0.1)

Subgroup analysis showed a nonsignificant trend for improved survival among AVR responders ( p = 0.09 and p = 0.15, diagnosis and enrollment, respectively) compared with non‐AVR responders in IPAH, but no difference in CTD‐PAH (Figure 3 ).

also in 5,406 other papers

a clear trendno p-value reported

18 Although initiation of CCB therapy in non‐IPAH responders is currently not recommended, there is a clear trend of increased survival among AVR responders across all group 1 PH patients.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.